![Simon Richard Hattersley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Simon Richard Hattersley
No más puestos en curso
Perfil
Mr. Simon R.
Hattersley is a Director at Endomagnetics Ltd.
and Chief Technical Officer-VivoSight at Michelson Diagnostics Ltd.
He is on the Board of Directors at Endomagnetics Ltd.
Antiguos cargos conocidos de Simon Richard Hattersley.
Empresas | Cargo | Fin |
---|---|---|
Michelson Diagnostics Ltd.
![]() Michelson Diagnostics Ltd. Medical SpecialtiesHealth Technology Michelson Diagnostics Ltd. develops medical imaging technology solutions. The firm develops, manufactures and markets VivoSight, a point-of-care, scanning device that provides clinicians with a unique, non-invasive tool for diagnosing a variety of skin pathologies. Its VivoSight uses light to provide continuous and accurate images of the sub-surface of the skin that can be easily interpreted by a clinician to assist in diagnosis and treatment guidance. The company was founded by Jonathan Denis Holmes, Martin Johns, Gordon McKenzie, Simon Richard Hattersley and Bill Gilkes in March 2006 and is headquartered in Maidstone, the United Kingdom. | Fundador | - |
Endomagnetics Ltd.
![]() Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Endomagnetics Ltd.
![]() Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
Michelson Diagnostics Ltd.
![]() Michelson Diagnostics Ltd. Medical SpecialtiesHealth Technology Michelson Diagnostics Ltd. develops medical imaging technology solutions. The firm develops, manufactures and markets VivoSight, a point-of-care, scanning device that provides clinicians with a unique, non-invasive tool for diagnosing a variety of skin pathologies. Its VivoSight uses light to provide continuous and accurate images of the sub-surface of the skin that can be easily interpreted by a clinician to assist in diagnosis and treatment guidance. The company was founded by Jonathan Denis Holmes, Martin Johns, Gordon McKenzie, Simon Richard Hattersley and Bill Gilkes in March 2006 and is headquartered in Maidstone, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Simon Richard Hattersley